Evidence map›Paper›PMID 27889207›Full record

ArticleStructure (London, England : 1993)2017

Dual Site Phosphorylation of Caspase-7 by PAK2 Blocks Apoptotic Activity by Two Distinct Mechanisms.

Scott J Eron, Kishore Raghupathi, Jeanne A Hardy

Open access · bronzeAbstract read
In one paragraph

Article in Structure (London, England : 1993), 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 26 papers.

0numbers the graph read from it
0cells of the map it votes in
26citing papers in PubMed
2.4field-weighted citation impact, top 11% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

26 citing papers in PubMed, 39 citations in OpenAlex.

  1. Review
  2. Article
  3. Article
  4. Article
  5. Review
  6. Article
  7. Review
  8. Article
  9. Review
  10. Review
  11. Article
  12. Article
  13. Article
  14. Caspases in the Developing Central Nervous System: Apoptosis and Beyond.Frontiers in cell and developmental biology · 2021
    Review
  15. Review
  16. Article
  17. Antioxidants (Basel, Switzerland) · 2019
    Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors at 1 institution in 1 country.

Scott J EronDepartment of Chemistry, University of Massachusetts Amherst, 104 LGRT, 710 North Pleasant Street, Amherst, MA 01003, USA.
Kishore RaghupathiDepartment of Chemistry, University of Massachusetts Amherst, 104 LGRT, 710 North Pleasant Street, Amherst, MA 01003, USA.
Jeanne A HardyDepartment of Chemistry, University of Massachusetts Amherst, 104 LGRT, 710 North Pleasant Street, Amherst, MA 01003, USA. Electronic address: hardy@chem.umass.edu.
University of Massachusetts Amherst · US

Funding

Control of Executioner Caspases with an allosteric switch - SupplementR01GM080532 · NIGMS · UNIVERSITY OF MASSACHUSETTS AMHERST · PI HARDY, JEANNE ANN · 2008 to 2022
$3.8M
NIGMS NIH HHS R01 GM080532NIGMS NIH HHS Y01 GM000080
6 · The paper itself

Abstract

Caspases, the cysteine proteases that execute apoptosis, are tightly regulated via phosphorylation by a series of kinases. Although all apoptotic caspases work in concert to promote apoptosis, different kinases regulate individual caspases. Several sites of caspase-7 phosphorylation have been reported, but without knowing the molecular details, it has been impossible to exploit or control these complex interactions, which normally prevent unwanted proliferation. During dysregulation, PAK2 kinase plays an alternative anti-apoptotic role, phosphorylating caspase-7 and promoting unfettered cell growth and chemotherapeutic resistance. PAK2 phosphorylates caspase-7 at two sites, inhibiting activity using two different molecular mechanisms, before and during apoptosis. Phosphorylation of caspase-7 S30 allosterically obstructs its interaction with caspase-9, preventing intersubunit linker processing, slowing or preventing caspase-7 activation. S239 phosphorylation renders active caspase-7 incapable of binding substrate, blocking later events in apoptosis. Each of these mechanisms is novel, representing new opportunities for synergistic control of caspases and their counterpart kinases.

Indexed as

ApoptosisBinding SitesCaspase 7Caspase 9Cell ProliferationCrystallography, X-RayDrug Resistance, NeoplasmEnzyme ActivationHumansMCF-7 CellsModels, MolecularNeoplasmsp21-Activated KinasesPhosphorylationSerineCASP7 protein, humanCASP9 protein, humanCaspase 7Caspase 9p21-Activated KinasesPAK2 protein, humanSerineapoptosiscaspasecysteine proteasekinasekinase-caspase interactionphosphomimeticphosphorylationphosphorylation-mediated inhibitionprodomainsteric block at active site

Identifiers

PMID27889207
PMCPMC5521178
OpenAlexW2556022833

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.